NCT03818386 2024-06-14
NANORAD2
University Hospital, Grenoble
Phase 2 Unknown
Clinical Trials
167 trialsNCT06291662 2024-03-04
Evaluation of Performance Characteristics and Applicability in Oncology of Devices Customized Medical Devices Made by 3D Printing
Meyer Children's Hospital IRCCS
Phase NA Unknown
NCT04530006 2024-02-23
Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma
CancerCare Manitoba
Phase NA Unknown
NCT06087393 2024-01-10
CONVIVO Endomicroscopy
Northwell Health
Phase NA Unknown
NCT04857905 2024-01-05
Dose-staged Gamma Knife Radiosurgery Versus Microsurgical Resection
Medical University of Vienna
Phase NA Unknown
NCT05192447 2024-01-03
REHABrain
The Greater Poland Cancer Centre
Phase NA Unknown
NCT03122197 2023-12-13
Study of Letrozole in Recurrent Gliomas
University of Cincinnati
Phase EARLY_PHASE1 Unknown
NCT05812534 2023-11-18
CBC
Second Affiliated Hospital of Nanchang University
Phase 2 Unknown
NCT03951142 2023-11-01
ImPRESS
Oslo University Hospital
Phase 2 Unknown
NCT06106997 2023-10-30
Clinical Feasibility of Brain Radiotherapy Using Synthetic CTs in an MRI-only Workflow
University of Erlangen-Nürnberg Medical School
Phase NA Unknown
NCT05144867 2023-10-17
SRSvsWBRT
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 3 Unknown
NCT02953717 2023-09-13
Cognitive Outcome After SRS or WBRT in Patients With Multiple Brain Metastases (CAR-Study B)
Elisabeth-TweeSteden Ziekenhuis
Phase NA Unknown
NCT04722237 2023-08-31
ACT NOW
Nottingham University Hospitals NHS Trust
Phase NA Unknown
NCT06014398 2023-08-28
Improving Survivorship and Health-related Quality of Life in Patients With Primary Brain Tumours
Royal College of Surgeons, Ireland
Phase NA Unknown
NCT01046123 2023-08-14
Volumetric Modulated Arc Therapy (VMAT) for Brain Metastases
British Columbia Cancer Agency
Phase NA Unknown
NCT05549414 2023-07-10
PPTS
P-Cure
Phase NA Unknown
NCT05732896 2023-06-22
NOLopioid
Turkish Society of Anesthesiology and Reanimation
Phase NA Unknown
NCT04737577 2023-06-18
G-SUMIT
Sunnybrook Health Sciences Centre
Phase NA Unknown
NCT04223999 2023-06-06
OptimalTTF-2
University of Aarhus
Phase 2 Unknown
NCT04553341 2023-06-01
Induction of Cortical Plasticity
Technical University of Munich
Phase NA Unknown
NCT05358340 2023-05-09
Dual Perfusion Imaging for Characterizing Vascular Architecture of Brain Lesions
University Health Network, Toronto
Phase NA Unknown
NCT05844605 2023-05-06
PREHABILITA
Institut Guttmann
Phase 1 Unknown
NCT03223675 2023-05-01
Neurocognitive Impact and Dose-Effect Relationship of Hippocampal Avoidance During Whole Brain Radiotherapy Plus Simultaneous Integrated Boost - A Prospective Follow-up Study
Chang Gung Memorial Hospital
Phase NA Unknown
NCT04712214 2023-04-25
Use of Non-invasive Optical Analysis in Neurosurgery
Imperial College London
Phase NA Unknown
NCT03613181 2023-04-24
ANGLeD
Angiochem Inc
Phase 3 Unknown
NCT05049707 2023-04-12
Does Perioperative Intravenous Magnesium Affect Postoperative Quality of Recovery in Craniotomy Surgery Patients?
Thomas Jefferson University
Phase 3 Unknown
NCT05743725 2023-02-24
Dexmedetomidine Versus Magnesium Sulphate in Patients Undergoing Craniotomy for Deeply Settled Intracranial Tumours
Assiut University
Phase NA Unknown
NCT04582968 2023-01-18
Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases
Fudan University
Phase 1/2 Unknown
NCT04831190 2023-01-18
ACE-Neuro
University of Calgary
Phase NA Unknown
NCT04211090 2022-11-16
CAP-BRAIN
Sun Yat-sen University
Phase 2 Unknown
NCT05588206 2022-10-20
Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer
First People's Hospital of Hangzhou
Phase 1/2 Unknown
NCT05573815 2022-10-10
Evaluation of Clinical Decision Support System for Brain Metastasis Using Brain MR Images
Heuron Inc.
Phase NA Unknown
NCT05477316 2022-07-28
A Study to Assess the Efficacy of Cerebellar IMRT Combined With Cerebral SRS in Patients With Brain Metastases
Hadassah Medical Organization
Phase NA Unknown
NCT05459441 2022-07-15
Efficacy and Safety Evaluation of Percutaneous Ommaya Capsule Injection of Autologous Bi-dimensional Specific T Cells in the Treatment of Glioma and in Combination With Pemetrexed in the Treatment of Brain/Meningeal Metastases
Shanghai Pudong Hospital
Phase EARLY_PHASE1 Unknown
NCT03243461 2022-06-06
HIT-HGG-2013
University of Göttingen
Phase 3 Unknown
NCT03226483 2022-06-03
INTRAMET
Universitätsmedizin Mannheim
Phase NA Unknown
NCT05018702 2022-06-01
ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases
Fudan University
Phase 2 Unknown
NCT05393492 2022-05-26
GREMO-LCA
University Hospital, Strasbourg, France
Phase NA Unknown
NCT05092802 2022-05-03
The Efficacy of HLX208 (BRAF V600E Inhibitor) for Refractory Primary Brain Tumors With BRAF Mutation After First-line Treatment
Shanghai Henlius Biotech
Phase 2 Unknown
NCT04334330 2022-05-02
Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China
Sun Yat-sen University
Phase 2 Unknown
NCT05326425 2022-04-20
Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI.
Seoul St. Mary's Hospital
Phase 2 Unknown
NCT05202899 2022-03-09
Effect of Sugammadex for Reversal of Rocuronium-induced Neuromuscular Block on Perioperative Management of Awake Craniotomy
Guangzhou General Hospital of Guangzhou Military Command
Phase 4 Unknown
NCT01951469 2022-03-08
Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer
Sun Yat-sen University
Phase 3 Unknown
NCT04967027 2022-03-02
Phase 1 Trial for Tumor Treating Field for Drug/Radiation Resistant Brain Metastases
Xiangya Hospital of Central South University
Phase EARLY_PHASE1 Unknown
NCT05177185 2022-02-16
HiSparCK
Ottawa Hospital Research Institute
Phase 2 Unknown
NCT03801200 2022-02-08
Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC
Hubei Cancer Hospital
Phase 2 Unknown
NCT05207904 2022-01-26
Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases
Sun Yat-sen University
Phase 2 Unknown
NCT02796261 2022-01-21
STELLAR
Orbus Therapeutics, Inc.
Phase 3 Unknown
NCT05199363 2022-01-20
Pediatric Patient Experience on a Diagnostic Path
Children's Memorial Health Institute, Poland
Phase NA Unknown
NCT05160818 2021-12-16
SATURNUS
Technical University of Munich
Phase NA Unknown